Impaired apoptosis of pulmonary endothelial cells is associated with intimal proliferation and irreversibility of pulmonary hypertension in congenital heart disease.

[1]  N. Voelkel,et al.  Simvastatin causes endothelial cell apoptosis and attenuates severe pulmonary hypertension. , 2006, American journal of physiology. Lung cellular and molecular physiology.

[2]  S. Sivaprasad.  Pegaptanib sodium for age-related macular degeneration , 2006 .

[3]  D. Guyer,et al.  Pegaptanib sodium for neovascular age-related macular degeneration: two-year safety results of the two prospective, multicenter, controlled clinical trials. , 2006, Ophthalmology.

[4]  S. Ylä-Herttuala,et al.  Biology of vascular endothelial growth factors , 2006, FEBS letters.

[5]  Thomas Brunner,et al.  Role of Endogenous Fas (CD95/Apo-1) Ligand in Balloon-Induced Apoptosis, Inflammation, and Neointima Formation , 2006, Circulation.

[6]  Y. Fukuchi,et al.  Downregulation of type II bone morphogenetic protein receptor in hypoxic pulmonary hypertension. , 2006, American journal of physiology. Lung cellular and molecular physiology.

[7]  M. Feldmann,et al.  Vascular endothelial growth factor signalling in endothelial cell survival: a role for NFkappaB. , 2006, Biochemical and biophysical research communications.

[8]  D. Stewart,et al.  Bone Morphogenetic Protein Receptor-2 Signaling Promotes Pulmonary Arterial Endothelial Cell Survival: Implications for Loss-of-Function Mutations in the Pathogenesis of Pulmonary Hypertension , 2006, Circulation research.

[9]  T. Peterson,et al.  Functional adaptation and remodeling of pulmonary artery in flow-induced pulmonary hypertension. , 2005, American journal of physiology. Heart and circulatory physiology.

[10]  W. Sessa,et al.  Endothelial nitric oxide synthase is critical for ischemic remodeling, mural cell recruitment, and blood flow reserve. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[11]  Y. Ko,et al.  Identification of p54(nrb) and the 14-3-3 Protein HS1 as TNF-alpha-inducible genes related to cell cycle control and apoptosis in human arterial endothelial cells. , 2005, Journal of biochemistry and molecular biology.

[12]  N. Voelkel,et al.  Initial apoptosis is followed by increased proliferation of apoptosis‐resistant endothelial cells , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[13]  S. Archer,et al.  Gene therapy targeting survivin selectively induces pulmonary vascular apoptosis and reverses pulmonary arterial hypertension. , 2005, The Journal of clinical investigation.

[14]  J. Martinovic,et al.  Developmental Changes in Endothelial Vasoactive and Angiogenic Growth Factors in the Human Perinatal Lung , 2005, Pediatric Research.

[15]  V. Aiello,et al.  Decreased numbers of T-lymphocytes and predominance of recently recruited macrophages in the walls of peripheral pulmonary arteries from 26 patients with pulmonary hypertension secondary to congenital cardiac shunts. , 2004, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[16]  M. Humbert,et al.  Cellular and molecular pathobiology of pulmonary arterial hypertension. , 2004, Journal of the American College of Cardiology.

[17]  R. Budhiraja,et al.  Endothelial Dysfunction in Pulmonary Hypertension , 2004, Circulation.

[18]  Jianxin Sun,et al.  Activation of the Phosphatidylinositol 3-Kinase/Protein Kinase Akt Pathway Mediates Nitric Oxide-Induced Endothelial Cell Migration and Angiogenesis , 2003, Molecular and Cellular Biology.

[19]  G. Semenza,et al.  Expression of angiogenesis‐related molecules in plexiform lesions in severe pulmonary hypertension: evidence for a process of disordered angiogenesis , 2001, The Journal of pathology.

[20]  A. Bogers,et al.  Enhanced expression of vascular endothelial growth factor in pulmonary plexogenic arteriopathy due to congenital heart disease , 2000, The Journal of pathology.

[21]  K. Kuwano,et al.  Expression of apoptosis‐regulatory genes in epithelial cells in pulmonary fibrosis in mice , 2000, The Journal of pathology.

[22]  M. Rabinovitch.  Pulmonary hypertension: pathophysiology as a basis for clinical decision making. , 1999, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[23]  S. Black,et al.  Increased endothelial NOS in lambs with increased pulmonary blood flow and pulmonary hypertension. , 1998, The American journal of physiology.

[24]  J. Zweier,et al.  Superoxide Generation from Endothelial Nitric-oxide Synthase , 1998, The Journal of Biological Chemistry.

[25]  M. Yacoub,et al.  High expression of endothelial nitric oxide synthase in plexiform lesions of pulmonary hypertension , 1998, The Journal of pathology.

[26]  L. Hillis,et al.  The Eisenmenger Syndrome in Adults , 1998, Annals of Internal Medicine.

[27]  J. Deanfield,et al.  Impairment of Endothelium‐Dependent Pulmonary Artery Relaxation in Children With Congenital Heart Disease and Abnormal Pulmonary Hemodynamics , 1993, Circulation.

[28]  C. Clelland,et al.  Impairment of pulmonary endothelium‐dependent relaxation in patients with Eisenmenger's syndrome , 1990, British journal of pharmacology.

[29]  A. Hislop,et al.  Pulmonary vascular development: normal values of peripheral vascular structure. , 1983, The American journal of cardiology.

[30]  A. Castañeda,et al.  Lung Biopsy in Congenital Heart Disease: A Morphometric Approach to Pulmonary Vascular Disease , 1978, Circulation.

[31]  L. Reid,et al.  A morphometric study of regional variation in lung structure in infants with pulmonary hypertension and congenital cardiac defect. A justification of lung biopsy. , 1978, British heart journal.

[32]  W. Jiang,et al.  Vascular endothelial growth factor-induced endothelial cell proliferation is regulated by interaction between VEGFR-2, SH-PTP1 and eNOS. , 2006, Microvascular research.

[33]  Y. Ko,et al.  Identification of p 54 nrb and the 14-3-3 Protein HS 1 as TNF-α-Inducible Genes Related to Cell Cycle Control and Apoptosis in Human Arterial Endothelial Cells , 2005 .

[34]  A. Bogers,et al.  Altered arterial expression patterns of inducible and endothelial nitric oxide synthase in pulmonary plexogenic arteriopathy caused by congenital heart disease. , 2001, American journal of respiratory and critical care medicine.